# A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate

> **NCT01198002** · PHASE3 · TERMINATED · sponsor: **Eli Lilly and Company** · enrollment: 1041 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** LY2127399
- **DRUG:** Placebo Q2W
- **DRUG:** Placebo Q4W
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT01198002
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-12
- **Primary completion:** 2012-12
- **Final completion:** 2014-01
- **Target enrollment:** 1041 (ACTUAL)
- **Why stopped:** Terminated not based on safety concerns, but due to insufficient efficacy.
- **Last updated:** 2018-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01198002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01198002, "A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01198002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*